Mitochondria as central regulators of cancer progression and antitumor immunity.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic concepts without primary human data or systematic review methodology
PubMed 42642272 · doi:10.1016/j.tem.2026.07.005
What was done
The authors synthesized existing literature on the regulatory roles of mitochondria in oncology, focusing on how mitochondrial metabolism, redox signaling, mitochondrial DNA (mtDNA) dynamics, and intercellular mitochondrial transfer influence cancer cell proliferation, metastatic dissemination, and tumor-immune cell interactions.
What was found
The abstract reports no quantitative data or specific numerical results. It summarizes qualitative mechanistic pathways showing that mitochondrial functional outputs sustain tumor growth, promote metastatic pathways, and contribute to immune cell exhaustion and senescence within the tumor microenvironment.
Why it matters
This synthesis connects basic mitochondrial biology to tumor immunology, highlighting how targeting mitochondrial pathways may provide opportunities to improve the effectiveness of current cancer immunotherapies.
Limits
The publication is a narrative review that does not include original clinical trial data, systematic search protocols, or meta-analytic pooling. Biological mechanisms and therapeutic concepts discussed reflect pre-clinical and theoretical frameworks rather than validated clinical outcomes.
Cited by
- contradicts Every known cancer genetic risk factor mutation impairs the efficiency of mitochondrial oxidative phosphorylation.